Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cdk5 and Abl enzyme substrate 1 (CABLES1) is a cyclin-dependent kinase binding protein that acts as a tumor suppressor gene, mainly regulating cell cycle progression and apoptosis through interactions with multiple cyclin-dependent kinases (CDK2, CDK3, CDK5) and non-receptor tyrosine kinases including Src, Abl, and Wee1[1][2]. CABLES1 modulates kinase activity, enhancing CDK5 activity (crucial for neuronal development) and inhibiting CDK2-mediated growth via the WEE1 pathway[2]. In addition, it potentiates p53/p73-induced cell death and impacts the Wnt/β-catenin signaling pathway in tumorigenesis; its loss activates β-catenin-dependent transcription and proliferation in cancer models, contributing to tumor progression. CABLES1 is frequently inactivated in human cancers by promoter hypermethylation and loss of heterozygosity, and its deficiency correlates with increased tumor formation, cell proliferation, and delayed cellular senescence[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cdk5 and Abl enzyme substrate 1 (CABLES1).